Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changbin Shi

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Circulation Research|May 4, 2018
Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional GrowthRomuald Girard, Hussein A Zeineddine, Janne Koskimäki, et al.
Stroke|November 24, 2016
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous MalformationsRobert Shenkar, Changbin Shi, Cecilia Austin, et al.
Translational Stroke Research|August 19, 2017
Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous MalformationsRomuald Girard, Hussein A Zeineddine, Maged D Fam, et al.
Neuro-Oncology|February 19, 2013
MiR-106a is an independent prognostic marker in patients with glioblastomaShiguang Zhao, Guang Yang, Yulong Mu, et al.
International Journal of Biological Macromolecules|March 22, 2026
Targeting OXCT1 with the methyl donor S-adenosylmethionine as a therapeutic strategy for cerebral cavernous malformationsYongqing Ye, Cong Yan, Xuyang Huang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 12, 2015
Inhibition of autophagy induced by quercetin at a late stage enhances cytotoxic effects on glioma cellsYunke Bi, Chen Shen, Chenguang Li, et al.
Biochemical and Biophysical Research Communications|June 26, 2025
Metformin limits cerebral cavernous malformation development by targeting KLF4-mediated mitochondrial damageCong Yan, Yongqing Ye, Nan Liu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 15, 2014
Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutationsRobert Shenkar, Changbin Shi, Tania Rebeiz, et al.
Journal of Neuroscience Methods|June 28, 2016
Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain diseaseRomuald Girard, Hussein A Zeineddine, Courtney Orsbon, et al.
Cell Communication and Signaling : CCS|January 9, 2024
Transcriptomic signatures of individual cell types in cerebral cavernous malformationYing Li, Romuald Girard, Abhinav Srinath, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Circulation Research|May 4, 2018
Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional GrowthRomuald Girard, Hussein A Zeineddine, Janne Koskimäki, et al.
Stroke|November 24, 2016
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous MalformationsRobert Shenkar, Changbin Shi, Cecilia Austin, et al.
Translational Stroke Research|August 19, 2017
Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous MalformationsRomuald Girard, Hussein A Zeineddine, Maged D Fam, et al.
Neuro-Oncology|February 19, 2013
MiR-106a is an independent prognostic marker in patients with glioblastomaShiguang Zhao, Guang Yang, Yulong Mu, et al.
International Journal of Biological Macromolecules|March 22, 2026
Targeting OXCT1 with the methyl donor S-adenosylmethionine as a therapeutic strategy for cerebral cavernous malformationsYongqing Ye, Cong Yan, Xuyang Huang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 12, 2015
Inhibition of autophagy induced by quercetin at a late stage enhances cytotoxic effects on glioma cellsYunke Bi, Chen Shen, Chenguang Li, et al.
Biochemical and Biophysical Research Communications|June 26, 2025
Metformin limits cerebral cavernous malformation development by targeting KLF4-mediated mitochondrial damageCong Yan, Yongqing Ye, Nan Liu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 15, 2014
Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutationsRobert Shenkar, Changbin Shi, Tania Rebeiz, et al.
Journal of Neuroscience Methods|June 28, 2016
Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain diseaseRomuald Girard, Hussein A Zeineddine, Courtney Orsbon, et al.
Cell Communication and Signaling : CCS|January 9, 2024
Transcriptomic signatures of individual cell types in cerebral cavernous malformationYing Li, Romuald Girard, Abhinav Srinath, et al.
Pageof 6